: Vivos Therapeutics’ stock soars as sleep apnea device gets regulatory clearance
Vivos Therapeutics jumped more than 270% after the FDA cleared the company's devices for severe sleep apnea.
Vivos Therapeutics jumped more than 270% after the FDA cleared the company's devices for severe sleep apnea.